Medtronic to buy Contego Medical for $380 million to expand stroke-prevention devices
The Financial (Finchannel) · · AI-summarised by FinFlash
Medtronic plans to acquire Contego Medical in a deal valued at $380 million, with potential further payments after closing. The purchase builds on an exclusive US distribution pact signed in January 2025 and adds the Neuroguard IEP Direct carotid system and Excipio thrombectomy devices. Closing is expected in Medtronic's fiscal third quarter, with minimal dilution to adjusted EPS in fiscal 2027 and 2028 and a neutral-to-accretive impact afterwards. Shares closed at A small bolt-on that deepens Medtronic's vascular franchise with limited earnings drag; supportive for medtech consolidation sentiment. Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.So What?
Understand the context